As in the overall cohort, we detected lower PEMT expression in postmenopausal women with fibrosis compared to milder NASH stages, although these analyses were limited by the number of individuals in the different NAFLD stages. This evidence concerns the gene PEMT and metabolic dysfunction-associated steatotic liver disease.